Technology developed by Pharmacology faculty used to detect potential life-threatening pregnancy complication
![pregnant_woman](/sites/g/files/oketem666/files/styles/3_2_480x320/public/media/images/Pregnant%2Bwoman%2Bprofile%2BUnsplash%2Bfreestocks_mid.jpg.webp?itok=B_VLJGbU)
The NanoVelcro Chip, developed by Crump Institute faculty Drs. Hsian-Rong Tseng and Yazhen Zhu, has been identified as a key tool for early screening of placenta accreta spectrum disorder.
The findings are published in Nature Communications.